PARIS — High-frequency repetitive transcranial magnetic stimulation (rTMS) is safe and effective in managing ataxia in patients with relapsing-remitting multiple sclerosis (RRMS), new research ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A novel ...
Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use as a short-term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis ...
Patient 1, a 49-year-old man with titubation, dizziness, and loss of balance from the age of 34 years, had deteriorating speech and handwriting. Cerebellar signs included moderate gait ataxia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback